Evercore ISI lowered the firm’s price target on Boston Scientific (BSX) to $112 from $113 and keeps an Outperform rating on the shares. Recovering ...

Detailed price information for Boston Scientific Corp (BSX-N) from The Globe and Mail including charting and trades.

Boston Scientific BSX has a stretched valuation, reflected in its Value Score of C. Shares of the company are trading at a ...

In this week’s View, Dr. Eagle looks at the lower risk of major adverse events in patients with left atrial appendage occlusion (LAAO) using the Watchman 2.4 device. He then discusses the impact of ...

Dual antiplatelet therapy (DAPT) was found to have a similar safety profile to oral anticoagulation (OAC) with aspirin after left atrial appendage occlusion (LAAO) with the Watchman FLX, according to ...

Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...

Boston Scientific saw a profit boom in the third quarter of the year, leading the company to increase its full-year forecast for 2025. The company is now projecting revenue growth of 20% for the ...

Fairfield Medical Center (FMC) has reached a significant milestone in stroke prevention, completing its 100th WATCHMAN. The WATCHMAN FLX Pro, a minimally invasive procedure, is designed to reduce ...

Baxter alerted customers to a safety issue involving its Novum IQ infusion pumps that has been potentially associated with two deaths and 79 severe injuries. Dental implant maker ZimVie has agreed to ...

Please provide your email address to receive an email when new articles are posted on . AF recurrence after catheter ablation was not linked to adverse outcomes, but a nonsignificant trend for worse ...

Boston Scientific Corporation BSX recently presented data supporting the use of the FARAPULSE Pulsed Field Ablation (“PFA”) system and the WATCHMAN Left Atrial Appendage Closure (“LAAC”) device during ...